GRN and frontotemporal dementia: Given the genetic loss-of-function nature of FTD-GRN, we embarked on a strategy to use an AAV gene transfer approach whereby a viral vector transduces neurons and other cells in the CNS with a copy of the GRN gene, wherein the GRN transgene remains episomal and constitutively expresses progranulin at sufficient levels to restore normal cellular function.